Tag Archives: Seoul

Stem Cells for Patients with Erectile Dysfunction

After more than a decade of short-term cures to erectile dysfunction, most aimed at symptoms rather than the underlying issues of nerve damage, a new approach has emerged from adult stem cell technology developed by RNL Bio. Dr. Ji Youl Lee and the RNL Stem Cell Technology Institute team, working at St. Mary’s Hospital in Seoul, found in animal studies that adipose (fat) derived adult human stem cells, grown in culture, were very effective in treating cavernous nerve injury.

When rats with cavernous nerve injury, the equivalent of erectile dysfunction in humans, were treated with RNL Bio’s patented
Read More…

SOUTH KOREA – Biotech Company Says It Will Cost Half to Clone Dogs

Cloning a Chow Chow will be easy and will also cost at least half of what it would cost to clone any other type of dog, announced a South Korean biotech company today while presenting new cloning technology.

But dog-owners – who pay 100,000 dollars or more to clone a pet – will still have to pay tens of thousands of dollars if they want to clone their beloved four-legged friends, and must be prepared for long waiting-lists, because most cloning at a commercial level involves dogs used for work, like police dogs used in airports.

The Rnl Bio company announced
Read More…

Neuron function damaged by Huntington’s restored by stem cells

Researchers from South Korea, Sweden, and the United States have collaborated on a project to restore neuron function to parts of the brain damaged by Huntington’s disease (HD) by successfully transplanting HD-induced pluripotent stem cells into animal models.

Induced pluripotent stem cells (iPSCs) can be genetically engineered from human somatic cells such as skin, and can be used to model numerous human diseases. They may also serve as sources of transplantable cells that can be used in novel cell therapies. In the latter case, the patient provides a sample of his or her own skin to the laboratory.

In the current
Read More…

Stem cells for diabetes from cloned embryos

And now there are three: in the wake of announcements from laboratories in Oregon and California that they had created human embryos by cloning cells of living people, a lab in New York announced on Monday that it had done that and more.

In addition to cloning the cells of a woman with diabetes, producing embryos and stem cells that are her perfect genetic matches, scientists got the stem cells to differentiate into cells able to secrete insulin.

That raised hopes for realizing a long-held dream of stem cell research, namely, creating patient-specific replacement cells for people with diabetes, Parkinson’s disease,
Read More…

SOUTH KOREA – South Korea also relaunches embryonic stem cell research

Image by erjkprunczyk via Flickr

After the decision of the United States to remove the ban preventing stem cell researchers from using public funding for experiments, legislators in South Korea have been put under pressure by scientists who have been aspiring to do experiments on stem cells from cloned human embryos.

Up until a few weeks ago the National Bioethics Committee continued to postpone a decision on the matter, but now thanks to the American president, it is increasingly probable that at most, by the end of April, researchers of the Cha Medical Institute of Seoul will be able to resume
Read More…